DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Claims 10-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 11/11/25.
The request for rejoinder will be considered at the appropriate time.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) claims 1-9 are rejected under 35 U.S.C. 102(a1) as being anticipated by Chandrasekharan et al (US 2011/0186518).
Chandrasekharan teaches hollow fiber membranes coated in the lumen with genistein, a hydroxyisoflavone (figure 3.) The coating is complete as is described in [0081] and [0082]. The hollow fiber membrane is made of polysulfone, etc., see claim 3. Genistein also coats the pores – see [0137], [0152] and [0164] – coated in the finger-like channels; genistein crystalizes at the pore interface. Thus all the claims are anticipated.
Claim(s) claims 1-3 and 6-9 are rejected under 35 U.S.C. 102(a1) as being anticipated by CN (CN110394066B.)
CN teaches a membrane modified by coating of a polyphenol compound (genistein, tec., see claim 5.) The support membrane is polysulfone, etc. Since the solution is coated on the entire surface is as in applicant’s process, genistein will also penetrate the pores. Thus claim 1-3 and 6-9 are anticipated.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KRISHNAN S MENON whose telephone number is (571)272-1143. The examiner can normally be reached Flexible, but generally Monday-Friday: 8:00AM-4:30PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Prem Singh can be reached at 5712726381. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KRISHNAN S MENON/Primary Examiner, Art Unit 1777
Prosecution Insights